Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient

Shah S., Budev M., Blazey H., Fairbanks K., Mehta A.

Source: Eur Respir J 2006; 27: 1066-1068
Journal Issue: May
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Shah S., Budev M., Blazey H., Fairbanks K., Mehta A.. Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient. Eur Respir J 2006; 27: 1066-1068

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary complications in renal transplant recipients
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease
Source: Eur Respir J 2009; 34: 1348-1356
Year: 2009



Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016


Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension
Source: Eur Respir J 2004; 24 : 703-707
Year: 2004



Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012



Pulmonary function in patients with end-stage renal disease and renal transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 56s
Year: 2004

Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation
Source: ERJ Open Res, 5 (1) 00168-2018; 10.1183/23120541.00168-2018
Year: 2019



Pulmonary hypertension in end-stage renal disease and post renal transplantation patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013


Paediatric lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=243
Year: 2003

Pulmonary complications in heart transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 181s
Year: 2004

Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012


Tuberculosis in patients on chronic dialysis and renal transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 416s
Year: 2004

Noninfectious pulmonary complications after organ transplantation
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=202
Year: 2005

Noninfectious complications
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=208
Year: 2003

Pulmonary veno-occlusive disease
Source: Eur Respir J 2016; 47:1518-1534
Year: 2016



Outcome of candidates for liver transplantation suffering from portopulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011